CYP1A1 and hepatocellular carcinoma: Previous studies found that administration of ANE to mice stimulates hepatic CYP enzyme activities [30], but arecoline inhibits the 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD)-induced CYP1A1 expression in hepatoma cells [31].